Reaction
Toxic Optic Neuropathy reporting signals
As of the last recalculation, Toxic Optic Neuropathy appears in 425 FAERS reports alongside 20 co-occurring drug terms. The strongest observed disproportionality signal is LINEZOLID (PRR 229.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Linezolid | 105 | 229.1 | 229.9 |
| Voriconazole Injection | 57 | 148.3 | 148.7 |
| Voriconazole | 61 | 114.7 | 114.9 |
| Pyrazinamide | 19 | 103.7 | 103.9 |
| Lubiprostone | 13 | 69.4 | 69.5 |
| Moxifloxacin | 19 | 69.1 | 69.2 |
| Isoniazid | 20 | 63.4 | 63.5 |
| Valganciclovir Hydrochloride Powder, | 14 | 58.1 | 58.2 |
| Rifampin | 16 | 55.7 | 55.8 |
| Moxifloxacin Hydrochloride | 20 | 50.6 | 50.7 |
| Rifampicin | 8 | 39.5 | 39.5 |
| Lamotirigine | 49 | 37.7 | 37.8 |
| Lamotrigine Extended-Release | 49 | 37.7 | 37.8 |
| Lamotrigine Chewable Dispersible | 49 | 37.7 | 37.8 |
| Valganciclovir | 14 | 37.6 | 37.6 |
| Valganciclovir Hydrochloride | 14 | 37.6 | 37.6 |
| Levetiracetam In Sodium Chloride | 49 | 34.9 | 34.9 |
| Levetiracetam Oral | 49 | 34.9 | 34.9 |
| Levetiracetam Injection | 49 | 34.9 | 34.9 |
| Lamivudine Oral | 17 | 34.2 | 34.3 |